EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Oligometastatic esophageal squamous cell carcinoma: a systematic review of current definitions and meta-analysis of local therapy outcomes

Motoo Nomura iD, Sebastiaan F C Bronzwaer iD, Tiuri E Kroese, Peter S N van Rossum iD, Jelle P Ruurda, Richard van Hillegersberg iD, Ken Kato iD, Takashi Ogata, Mitsuro Kanda iD, Yoichi Hamai, Yasuhiro Tsubosa, Takako Yoshii und 6 weitere

Diseases of the Esophagus · 02.07.2026 · 39 (4)

DOI: 10.1093/dote/doag078 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Diseases of the Esophagus, online erschienen am 03.08.2026. Verfasst von Motoo Nomura und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current European expert consensus definitions for esophagogastric oligometastatic disease (OMD) primarily relate to adenocarcinoma. Oligometastatic esophageal squamous cell carcinoma (OMESQ) may require a distinct definition and treatment strategy. This systematic review and meta-analysis aimed to identify applied OMESQ definitions and assess the impact of local treatment on overall survival (OS). A systematic search of PubMed, Embase, CENTRAL, and ClinicalTrials.gov was conducted (February 2026). Studies or protocols were eligible if they reported an OMESQ definition or outcomes of local treatment in patients with limited metastatic ESCC. The primary outcomes were the maximum number of involved organs and metastases defined as OMD. Agreement across studies was scored as absent/poor (< 50%), fair (50%–75%), or strong (≥ 75%). A meta-analysis of OS after local treatment (+/− systemic therapy) versus systemic therapy alone was conducted through a random-effects pooled analysis of hazard ratios (HRs). Of the 3844 screened articles, 27 studies (23 retrospective, 4 prospective [one randomized]) and 7 protocols were included. Agreement was observed for defining synchronous OMESQ as disease in one organ with ≤3 metastases and metachronous OMESQ as disease in one organ with ≤2 metastases. Across 10 studies, meta-analysis showed that local treatment (+/− systemic therapy) was associated with improved OS compared with systemic therapy alone (pooled HR 0.61, 95% confidence interval: 0.52–0.72; I2 = 50.7%). Current literature and trial protocols considers OMESQ as ≤3 synchronous or ≤ 2 metachronous metastases in 1 organ. Local treatment is associated with improved OS compared with systemic therapy alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaHumansTreatment OutcomeNeoplasm MetastasisFemaleMale

Stichwörter der Autor:innen

chemotherapyesophageal cancermetastasisradiotherapysurgery

Autor:innen und Institutionen

  • Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan.
  • Department of Head and Neck Oncology and Innovative Treatment, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Surgery, UMC - University Medical Center Utrecht, Utrecht, Netherlands.
  • Department of Radiation Oncology, Amsterdam UMC - Vrije University Medical Centre (VUmc), Amsterdam, Netherlands.
  • Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.

ORCID-Profile: Motoo Nomura, Sebastiaan F C Bronzwaer, Peter S N van Rossum, Richard van Hillegersberg, Ken Kato, Mitsuro Kanda, Katsuyuki Sakanaka, Satoru Matsuda, Takahiro Tsushima, Hiroya Takeuchi

Zitieren

APA

Nomura, M., Bronzwaer, S. F. C., Kroese, T. E., van Rossum, P. S. N., Ruurda, J. P., van Hillegersberg, R., Kato, K., Ogata, T., Kanda, M., Hamai, Y., Tsubosa, Y., Yoshii, T., Furuta, M., Sakanaka, K., Matsuda, S., Tsushima, T., Laarhoven, H. W. M., & Takeuchi, H. (2026). Oligometastatic esophageal squamous cell carcinoma: a systematic review of current definitions and meta-analysis of local therapy outcomes. Diseases of the Esophagus, 39(4). https://doi.org/10.1093/dote/doag078

Vancouver

Nomura M, Bronzwaer SFC, Kroese TE, van Rossum PSN, Ruurda JP, van Hillegersberg R, et al. Oligometastatic esophageal squamous cell carcinoma: a systematic review of current definitions and meta-analysis of local therapy outcomes. Diseases of the Esophagus. 2026;39(4). doi:10.1093/dote/doag078

BibTeX
@article{Nomura2026,
  author = {Nomura, Motoo and Bronzwaer, Sebastiaan F C and Kroese, Tiuri E and van Rossum, Peter S N and Ruurda, Jelle P and van Hillegersberg, Richard and Kato, Ken and Ogata, Takashi and Kanda, Mitsuro and Hamai, Yoichi and Tsubosa, Yasuhiro and Yoshii, Takako and Furuta, Mitsuhiro and Sakanaka, Katsuyuki and Matsuda, Satoru and Tsushima, Takahiro and Laarhoven, Hanneke W M and Takeuchi, Hiroya},
  title = {Oligometastatic esophageal squamous cell carcinoma: a systematic review of current definitions and meta-analysis of local therapy outcomes},
  journal = {Diseases of the Esophagus},
  year = {2026},
  volume = {39},
  number = {4},
  doi = {10.1093/dote/doag078}
}
Kostenlos starten →